The Hepatitis C Drugs Market comprises antiviral medications aimed at eradicating or suppressing the hepatitis C virus (HCV) to prevent chronic liver damage. Key product categories include direct-acting antivirals (DAAs) like sofosbuvir, ledipasvir, and combination therapies that offer simplified dosing regimens, shorter treatment durations, and higher sustained virologic response rat... https://www.patreon.com/posts/hepatitis-c-to-130666890?utm_medium=clipboard_copy&utm_source=copyLink&utm_campaign=postshare_creator&utm_content=join_link